NCT01545583 - A Study of LY3016859 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

LY3016859 intravenous

Administered intravenously

DRUG

Placebo intravenous

Administered intravenously

DRUG

LY3016859 subcutaneous

Administered subcutaneously

DRUG

Placebo subcutaneous

Administered subcutaneously

Trial Locations (1)

NW10 7EW

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY